Posts by: admin

News

In a recent study titled “Harnessing the power of Vδ2 cells in cancer immunotherapy”, published ahead of print in the Clinical And Experimental Immunology journal, a group of researchers from St. ... Read more

December 4, 2014December 4, 2014

TESARO And AnaptysBio Expand Collaboration With Novel Bispecific Antibody Candidate

News

During the American Association for Cancer Research (AACR) Conference in Orlando, TESARO, Inc. and AnaptysBio, Inc., announced the expansion of their immuno-oncology partnership and exclusive license agreement to incorporate the ... Read more

November 28, 2014November 28, 2014

Study Finds Key Mechanism For Immunotherapy Responses in Melanoma Patients

News

In a recent study titled “Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma”, published in The New England Journal of Medicine, a team of researchers from the Memorial ... Read more

November 21, 2014November 21, 2014

MabVax’s Shows Dual-Labeled Antibody Can Detect and Guide Surgical Removal of Pancreatic Cancer

News

During the World Molecular Imaging Congress in Seoul, South Korea, MabVax Therapeutics Holdings, Inc. together with the Department of Radiology at Memorial Sloan-Kettering Cancer Center (MSKCC) presented the latest results on ... Read more

November 20, 2014November 20, 2014

Champions Presents ImmunoGraft Technology During Symposium

News

Champions Oncology, a company developing solutions to personalize oncology drugs, has presented two research studies during the 26th EORTC-NCI-AACR Symposium that took place earlier this week in Barcelona, Spain. During the presentations, ... Read more

November 17, 2014November 18, 2014

Curiox Biosystems Hosted The First Annual Primary Immune Cell Assay Development and Screening Meeting

News

Curiox Biosystems has presented the first Primary Immune Cell Assay Development and Screening Workshop, with the collaboration of the Academic Drug Discovery Consortium and the NIH aDREAM conference (Development of Robust Experimental ... Read more

November 13, 2014November 18, 2014

Generex Announces Latest Results On Its AE37 Breast Cancer Vaccine

News

Generex Biotechnology Corporation has announced the latest scientific results concerning its AE37 cancer vaccine, being developed by Antigen Express, Inc., were presented at the 29th Annual Meeting & Associated Programs of ... Read more

November 5, 2014November 5, 2014

AstraZeneca, Pharmacyclics And Janssen Partner On Immuno-Oncology Trials For Hematologic Cancers

News

AstraZeneca, Pharmacyclics, Inc. and Janssen Research & Development LLC have announced a clinical trial collaboration to assess the efficacy and safety of combining AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor, MEDI4736, with IMBRUVICA (ibrutinib), an ... Read more

November 4, 2014November 4, 2014

Immunotherapy Among Cleveland Clinic’s Top 10 Medical Innovations for 2015

News

Immunotherapy was listed in Cleveland Clinic’s 9th annual list of top 10 medical innovations for 2015. This list, selected by a panel of 110 Cleveland Clinic physicians and scientists, includes ... Read more

November 3, 2014

MD Anderson’s Moon Shots Program Offers Innovative Immunotherapeutic Approaches

News

The University of Texas MD Anderson Cancer Center’s Moon Shots Program is an innovative approach for cancer detection, prevention, survival and treatment, that includes unique combination clinical trials, advanced molecular analysis ... Read more